According to research on colorectal cancer (CRC) outcomes, recurrence affects a significant percentage of patients after initial treatment, most commonly within the first two to three years. Recurrence doesn’t mean you’re out of options. New, targeted therapies are changing the treatment landscape. Recurrent CRC means cancer has returned after a period of remission. It can […]

After treatment for colorectal cancer (CRC), it’s natural to wonder what steps you can take to reduce the risk of recurrence. While no lifestyle change can eliminate that risk entirely, new research is providing clearer, evidence-based guidance. According to Dr. Scott Kopetz of MD Anderson Cancer Center, this area has historically been difficult to study […]

Finishing treatment for colorectal cancer (CRC) is a major milestone. While it can bring a sense of relief, it’s also common to feel a bit uncertain about what comes next. One important part of this next phase is your follow-up care, which helps monitor your health and check for any signs that cancer may have […]

A diagnosis of colorectal cancer (CRC) often comes with a flood of information about surgery, chemotherapy, targeted therapies, and immunotherapy. Alongside these established treatments, clinical trials offer another path to explore. For some patients, trials provide access to promising new therapies that aren’t yet available outside of research settings. They also play a crucial role […]